Headache Evaluation and Treatment

Premier Pulse     June 2021

At the Clinical Neuroscience Institute’s (CNSI) Headache Center, we offer broad treatment options for patients suffering from a variety of headache symptoms, including migraines, tension-type, cluster, and post-traumatic headache disorders, in addition to others. Treatments include the use of peripheral nerve blocks, trigger point injections, and Botox therapy.

Outpatient infusion therapy is a vital option for patients requiring more intensive care than home treatments or office visits can provide, and is a helpful tool to keep them out of the emergency room. New outpatient infusion options are available as well that serve as preventive treatment.

Candidates for outpatient infusion therapy include:

  • Patients with migraine headaches lasting more than 72 hours and not responding to conventional medications
  • Patients suffering from acute migraine attacks for less than 72 hours, but are debilitating, and not responding to conventional home medications
  • Patients suffering from headaches due to medication overuse, from medications that can be safely discontinued as an outpatient

CNSI also offers inpatient evaluation and infusion therapy options.

Candidates for this treatment include:

  • Patients with disabling chronic migraine
  • Patients with medication overuse headache from medications that may not be safely discontinued in the outpatient setting
  • Patients with other types of acute or chronic headache who need further diagnostic evaluation and treatment
  • Patients who need more intensive therapy than can be provided in the outpatient infusion center

To refer a patient, Premier Health EPIC users should search location/department “Clinical Neuroscience Institute.”

Non-Premier Health EPIC users should call (937) 208-4200 or use the CNSI referral sheet.

1508203209 1063538783

Richard J. Kim, MD

Mark N. Youssef, MD

Marie Chambers, MSN, APN-BC


Back to the June 2021 issue of Premier Pulse